Non-Invasive Brain-Computer Interface for Virtual Object Control
Public ClinicalTrials.gov record NCT02071485. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A brain-computer interface (BCI) is a system that provides a separate output pathway for neurological signals whereby they can be interpreted to determine the user's intended cognitive action. Utilizing EEG-based sensorimotor rhythms (SMRs) generated in the motor cortex has allowed subjects to control virtual computer cursors in up to three dimensions by simply imagining the movement of a specified body part. Nevertheless, the scalp EEG signals are smeared by the volume conduction effect and measurement noise. The overall hypothesis of this study is that EEG-based virtual object control may help reveal optimal motor imagination tasks best used in a BCI. The PI's hypotheses include: (1) The use of advanced signal processing techniques will better reveal characteristics of EEG signals that represent the underlying motor cognitive function of the subject; (2) BCI systems based on SMR generated using motor imaginations will allow effective control of a virtual object in real time; (3) EEG imaging techniques will provide insight into the areas of cortical activation during a motor imagery task that can be utilized to increase the spatial resolution of non-invasive BCI's.
Study identification
- NCT ID
- NCT02071485
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 205 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2014
- Primary completion
- Jan 7, 2018
- Completion
- Jan 7, 2018
- Last update posted
- Jan 17, 2018
2014 – 2018
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Nils Hasselmo Hall at the University of Minnesota - Twin Cities campus | Minneapolis | Minnesota | 55455 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02071485, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 17, 2018 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02071485 live on ClinicalTrials.gov.